SPERO THERAPEUTICS INC (SPRO:NASDAQ)
$1.2 0.06 (5.2632%)
Analysed SPERO THERAPEUTICS INC (SPRO:NASDAQ) News Sources
Spero Therapeutics Announces $105 Million Non-Recourse Non-Dilutive Financing Backed by a Portion of Utebzi Milestones & Royalties
14-07-2026
yahoo.com
J&J dips despite upbeat outlook; AstraZeneca, Spero cut China deals
15-07-2026
biopharmadive.com
Innovent licenses IBI355 rights to Spero for up to $1.1bn
15-07-2026
hospitalmanagement.net
Spero Therapeutics Appoints Debra Jeske Zack, M.D., Ph.D., as Chief Medical Officer
27-07-2026
yahoo.com
Spero Therapeutics to Report Second Quarter 2026 Financial Results and Provide Business Update on August 12, 2026
04-08-2026
yahoo.com
Spero Therapeutics Announces Second Quarter 2026 Operating Results and Provides Business Update
12-08-2026
yahoo.com
Spero Therapeutics (SPRO) Q2 2026 Earnings Call Transcript
19-08-2026
fool.com
Spero Therapeutics to Present at H.C. Wainwright 28th Annual Global Investment Conference
02-09-2026
yahoo.com
Spero Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
03-09-2026
yahoo.com
Spero Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
02-10-2026
yahoo.com
What is the current price of SPERO THERAPEUTICS INC (SPRO:NASDAQ)?
The current price of SPERO THERAPEUTICS INC (SPRO:NASDAQ) is $1.2.
SPERO THERAPEUTICS INC (SPRO:NASDAQ) absolute price change since previous trading day?
The absolute price change of SPERO THERAPEUTICS INC (SPRO:NASDAQ) since the previous trading day is $0.06.
SPERO THERAPEUTICS INC (SPRO:NASDAQ) percentage price change since previous trading day?
The percentage price change of SPERO THERAPEUTICS INC (SPRO:NASDAQ) since the previous trading day is 5.2632%.
What is the most recent average sentiment score for SPERO THERAPEUTICS INC (SPRO:NASDAQ)?
The most recent average sentiment score for SPERO THERAPEUTICS INC (SPRO:NASDAQ) is 81 out of 100.
What is the most recent average sentiment for SPERO THERAPEUTICS INC (SPRO:NASDAQ)?
The most recent sentiment for SPERO THERAPEUTICS INC (SPRO:NASDAQ) is .
SEC-8K** Filing Available For SPERO THERAPEUTICS INC (SPRO:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.